BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 21389085)

  • 1. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S; Tzotzas T; Kaltsas T; Krassas GE
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
    Liu Y; Li Q; Xu Y; Chen Y; Men Y
    PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malformations following methimazole exposure in utero: an open issue.
    Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid dysfunction in pregnant women: clinical dilemmas].
    Vissenberg R; Goddijn M; Mol BW; van der Post JA; Fliers E; Bisschop PH
    Ned Tijdschr Geneeskd; 2012; 156(49):A5163. PubMed ID: 23218031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
    Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
    Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.